Chemours Appoints Michael Foley as President of Titanium Technologies; Announces Departure of Damián Gumpel
Chemours (NYSE:CC) had its price target lowered by analysts at JPMorgan Chase & Co. from $15.00 to $13.00. They now have a "neutral" rating on the stock.
Chemours (NYSE:CC) had its price target lowered by analysts at UBS Group AG from $21.00 to $18.00. They now have a "buy" rating on the stock.
Chemours (NYSE:CC) had its price target lowered by analysts at Truist Financial Corporation from $21.00 to $18.00. They now have a "buy" rating on the stock.
Chemours (NYSE:CC) had its price target lowered by analysts at Royal Bank Of Canada from $19.00 to $17.00. They now have an "outperform" rating on the stock.